Using breath testing to track lung cancer treatment
Part of Cancer, Lungs & breathing clinical trials.
This trial uses a special breath test (E-Nose) to monitor how well treatment is working in people with non-small cell lung cancer. You just breathe into a device, and it measures compounds in your breath.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have non-small cell lung cancer that has not been treated yet.
- Your cancer is stage I and can be removed with surgery, or stage II to IIIB and can be treated with therapy before surgery.
- You must be able to perform daily activities with little or no help (ECOG score 0–2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how tumor and blood biomarker results can guide treatment for people with non-small cell lung cancer (NSCLC). Depending on the cancer stage, it may follow standard-of-care treatment plans around surgery or first-line immunotherapy.
This trial uses advanced gene sequencing technology on blood and tumor tissue samples from people with non-small cell lung cancer. The goal is to see if this testing can help doctors better predict which treatments will work and detect if the cancer comes back early.
This study uses a special blood test to look for tiny traces of lung cancer after surgery. It aims to find “minimal residual disease,” meaning cancer cells that may still be hiding after your tumor is removed.
This study looks for cancer cells that travel through the blood or spread through air spaces in the lungs of people with early-stage lung cancer. The goal is to understand how these cells affect the disease, and it may help doctors plan better treatment in the future.
This trial is for people with stage IIA to IIIB non-small cell lung cancer that can be removed by surgery. It tests if certain white blood cells (neutrophils) can help predict how well chemotherapy combined with immunotherapy works before surgery.
This study is testing a special breath test (called an e-nose) to see if it can tell how well your treatment is working for malignant pleural mesothelioma. It is a non-invasive way to monitor your response to therapy.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.